Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument

Objective Gastrointestinal tract (GIT) involvement occurs in ∼90% of patients with systemic sclerosis (SSc) and has a major impact on health‐related quality of life (HRQOL). We developed an HRQOL instrument for persons with SSc. Methods The Scleroderma Gastrointestinal Tract 1.0 (SSC‐GIT 1.0) survey...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 2007-10, Vol.57 (7), p.1280-1286
Hauptverfasser: Khanna, Dinesh, Hays, Ron D., Park, Grace S., Braun‐Moscovici, Yolanda, Mayes, Maureen D., McNearney, Terry A., Hsu, Vivien, Clements, Philip J., Furst, Daniel E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective Gastrointestinal tract (GIT) involvement occurs in ∼90% of patients with systemic sclerosis (SSc) and has a major impact on health‐related quality of life (HRQOL). We developed an HRQOL instrument for persons with SSc. Methods The Scleroderma Gastrointestinal Tract 1.0 (SSC‐GIT 1.0) survey was developed after an extensive literature search, solicitation and consideration of experts' opinions, and 2 focus groups of 16 subjects with SSc and GIT involvement. A 75‐item, self‐reported measure assessing bowel involvement, emotional well‐being, and social functioning was administered to subjects with SSc and GIT involvement. Also, subjects completed the Short Form 36 and rated the severity of their GIT symptoms (very mild to very severe), and items were transformed linearly to a scale with a possible range of 0 (worse health) to 100 (better health). Evaluation of psychometric properties included internal consistency reliability, test–retest reliability (1.3‐week median time interval), multitrait scaling analysis, and exploratory factor analysis. Results Study participants (n = 88) were primarily female (95.5%), white (79.3%), and had a mean age of 52.4 years. Self‐rated severity of GIT involvement ranged from very mild or mild (36.0%) to moderate (44.0%) to severe or very severe (20.0%). Of 75 items, 23 had low item‐total correlations (≤0.39) and were excluded, leaving a 52‐item instrument. Analyses supported 6 multi‐item HRQOL scales: reflux/indigestion, diarrhea, constipation, pain, emotional well‐being, and social functioning. Test–retest reliability estimates ranged 0.69–0.90 and Cronbach's alpha ranged 0.69–0.93. Participants who rated their GIT disease as mild had the highest scores (better health) on all 6 scales; participants who rated their GIT as severe had the lowest scores (poor health). Conclusion The results support the reliability and validity of the SSC‐GIT 1.0 as a measure of SSc GIT involvement. Further research is needed to examine the ability to detect change over time and define minimally important differences.
ISSN:0004-3591
0893-7524
1529-0131
1529-0123
DOI:10.1002/art.22987